The flexibility and scalability of our Olink® Explore platform can be utilized either to screen our entire library of 3072 assays, or in studies that focus on one or several of the eight Explore 384-plex panels that make up the Explore 3072 protein library.
The panel includes a mix of established markers related to neurobiological processes and neurological diseases (e.g. neural development, axon guidance, synaptic function, or specific conditions such as Alzheimer’s disease), as well as some exploratory proteins.
The Explore 384 Neurology and Neurology II panels offer simultaneous analysis of 384 protein biomarkers using just 1 µL of biological sample, and all assays are subject to Olink’s strict technical validation and Quality Control procedures.
The assays in different Explore 384 panels are divided into different probe pools, called blocks, with different sample dilution factors to ensure optimal read-out quality.
| The Neurology panel › | 1:1 | 1:10 | 1:100 | |
| The Neurology II panel › | 1:1 | 1:10 | 1:100 |
Note that relevant neurology biomarkers can also be placed in other Explore 384 panels for optimal readout quality.
Our technical validation of assays are performed in vitro using recombinant analytes. All technical validation data reported on the biomarker pages are based on these in vitro assays.
2947
Biomarker assays
~881 million
Protein data points generated
886
Publications listed on website